Polycystic Ovary Syndrome: The Controversy of Diagnosis by Ultrasound

 

 Buy Article Permissions and Reprints

ABSTRACT

Polycystic ovary syndrome (PCOS) is a heterogeneous endocrine disorder. The criteria used to establish the diagnosis remain controversial. The 1990 National Institutes of Health conference guidelines required a combination of both chronic anovulation and clinical/or biochemical signs of hyperandrogenism. These criteria were revised in 2003 at the Rotterdam European Society of Human Reproduction and Embryology/American Society of Reproductive Medicine consensus workshop to include ultrasound polycystic ovarian morphology (PCOM) as one of the two of three criteria necessary for establishing the diagnosis of PCOS. The inclusion of PCOM sparked a controversy as it broadens the population of women who meet the criteria for PCOS and allows for the creation of two phenotypically different patient populations who previously would have been excluded. The ultrasound findings, which are consistent with PCOM, include an assessment of follicle number and/or ovarian volume. As technology advances with two-dimensional and three-dimensional ultrasound, our ability to discretely evaluate independent portions of the ovary may help to redefine the criteria of PCOM and thus standardize for clinical and research interests a more specific descriptor for PCOM.

REFERENCES

• 1 Azziz R, Woods K S, Reyna R, Key T J, Knochenhauer E S, Yildiz B O. The prevalence and features of the polycystic ovary syndrome in an unselected population.  J Clin Endocrinol Metab. 2004;  89 2745-2749
  CrossrefPubMedGoogle Scholar
• 2 Stein I, Leventhal M. Amenorrhoea associated with bilateral polycystic ovaries.  Am J Obstet Gynecol. 1935;  29 181-185
  PubMedGoogle Scholar
• 3 Rebar R, Judd H L, Yen S S, Rakoff J, Vandenberg G, Naftolin F. Characterization of the inappropriate gonadotropin secretion in polycystic ovary syndrome.  J Clin Invest. 1976;  57 1320-1329
  CrossrefPubMedGoogle Scholar
• 4 Kalro B N, Loucks T L, Berga S L. Neuromodulation in polycystic ovary syndrome.  Obstet Gynecol Clin North Am. 2001;  28 35-62
  CrossrefPubMedGoogle Scholar
• 5 Lobo R A. Disturbances of androgen secretion and metabolism in polycystic ovary syndrome.  Clin Obstet Gynaecol. 1985;  12 633-647
  PubMedGoogle Scholar
• 6 Dunaif A. Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis.  Endocr Rev. 1997;  18 774-800
  CrossrefPubMedGoogle Scholar
• 7 Dunaif A, Segal K R, Futterweit W, Dobrjansky A. Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome.  Diabetes. 1989;  38 1165-1174
  CrossrefPubMedGoogle Scholar
• 8 Balen A H, Laven J S, Tan S L, Dewailly D. Ultrasound assessment of the polycystic ovary: international consensus definitions.  Hum Reprod Update. 2003;  9 505-514
  CrossrefPubMedGoogle Scholar
• 9 Azziz R, Marin C, Hoq L, Badamgarav E, Song P. Health care-related economic burden of the polycystic ovary syndrome during the reproductive life span.  J Clin Endocrinol Metab. 2005;  90 4650-4658
  CrossrefPubMedGoogle Scholar
• 10 Azziz R. Diagnostic criteria for polycystic ovary syndrome: a reappraisal.  Fertil Steril. 2005;  83 1343-1346
  CrossrefPubMedGoogle Scholar
• 11 Ehrmann D A, Liljenquist D R, Kasza K, Azziz R, Legro R S, Ghazzi M N. Prevalence and predictors of the metabolic syndrome in women with polycystic ovary syndrome.  J Clin Endocrinol Metab. 2006;  91 48-53
  CrossrefPubMedGoogle Scholar
• 12 The Rotterdam ESHRE/ASRM-sponsored PCOS consensus workshop group . Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS).  Hum Reprod. 2004;  19 41-47
  CrossrefPubMedGoogle Scholar
• 13 Boomsma C M, Eijkemans M J, Hughes E G, Visser G H, Fauser B C, Macklon N S. A meta-analysis of pregnancy outcomes in women with polycystic ovary syndrome.  Hum Reprod Update. 2006;  12 673-683
  CrossrefPubMedGoogle Scholar
• 14 Zawadski J, Dunaif A. Diagnostic criteria for polycystic ovary syndrome: towards a rational approach. In: Dunaif A, Givens J, Haseltine F Polycystic Ovary Syndrome. Boston, MA; Blackwell Scientific 1992: 377-384
  Google Scholar
• 15 Azziz R. PCOS: a diagnostic challenge.  Reprod Biomed Online. 2004;  8 644-648
  CrossrefPubMedGoogle Scholar
• 16 Polson D W, Adams J, Wadsworth J, Franks S. Polycystic ovaries-a common finding in normal women.  Lancet. 1988;  1 870-872
  PubMedGoogle Scholar
• 17 Carmina E, Lobo R A. Do hyperandrogenic women with normal menses have polycystic ovary syndrome?.  Fertil Steril. 1999;  71 319-322
  CrossrefPubMedGoogle Scholar
• 18 Swanson M, Sauerbrei E E, Cooperberg P L. Medical implications of ultrasonically detected polycystic ovaries.  J Clin Ultrasound. 1981;  9 219-222
  CrossrefPubMedGoogle Scholar
• 19 Adams J, Franks S, Polson D W et al.. Multifollicular ovaries: clinical and endocrine features and response to pulsatile gonadotropin releasing hormone.  Lancet. 1985;  2 1375-1379
  PubMedGoogle Scholar
• 20 Goldstein S R. Incorporating endovaginal ultrasonography into the overall gynecologic examination.  Am J Obstet Gynecol. 1990;  162 625-632
  PubMedGoogle Scholar
• 21 Jonard S, Robert Y, Cortet-Rudelli C, Pigny P, Decanter C, Dewailly D. Ultrasound examination of polycystic ovaries: is it worth counting the follicles?.  Hum Reprod. 2003;  18 598-603
  CrossrefPubMedGoogle Scholar
• 22 Dewailly D, Catteau-Jonard S, Reyss A C, Maunoury-Lefebvre C, Poncelet E, Pigny P. The excess in 2-5 mm follicles seen at ovarian ultrasonography is tightly associated to the follicular arrest of the polycystic ovary syndrome.  Hum Reprod. 2007;  22 1562-1566
  CrossrefPubMedGoogle Scholar
• 23 Conway G S, Honour J W, Jacobs H S. Heterogeneity of the polycystic ovary syndrome: clinical, endocrine and ultrasound features in 556 patients.  Clin Endocrinol (Oxf). 1989;  30 459-470
  PubMedGoogle Scholar
• 24 Jonard S, Robert Y, Dewailly D. Revisiting the ovarian volume as a diagnostic criterion for polycystic ovaries.  Hum Reprod. 2005;  20 2893-2898
  CrossrefPubMedGoogle Scholar
• 25 Erickson G F, Magoffin D A, Dyer C A, Hofeditz C. The ovarian androgen producing cells: a review of structure/function relationships.  Endocr Rev. 1985;  6 371-399
  PubMedGoogle Scholar
• 26 Al-Took S, Watkin K, Tulandi T, Tan S L. Ovarian stromal echogenicity in women with clomiphene citrate-sensitive and clomiphene citrate-resistant polycystic ovary syndrome.  Fertil Steril. 1999;  71 952-954
  CrossrefPubMedGoogle Scholar
• 27 Buckett W M, Bouzayen R, Watkin K L, Tulandi T, Tan S L. Ovarian stromal echogenicity in women with normal and polycystic ovaries.  Hum Reprod. 1999;  14 618-621
  CrossrefPubMedGoogle Scholar
• 28 Fulghesu A M, Ciampelli M, Belosi C, Apa R, Pavone V, Lanzone A. A new ultrasound criterion for the diagnosis of polycystic ovary syndrome: the ovarian stroma/total area ratio.  Fertil Steril. 2001;  76 326-331
  CrossrefPubMedGoogle Scholar
• 29 Fulghesu A M, Angioni S, Frau E et al.. Ultrasound in polycystic ovary syndrome-the measuring of ovarian stroma and relationship with circulating androgens: results of a multicentric study.  Hum Reprod. 2007;  22 2501-2508
  CrossrefPubMedGoogle Scholar
• 30 Battaglia C, Genazzani A D, Artini P G, Salvatori M, Giulini S, Volpe A. Ultrasonographic and color Doppler analysis in the treatment of polycystic ovary syndrome.  Ultrasound Obstet Gynecol. 1998;  12 180-187
  PubMedGoogle Scholar
• 31 Carmina E, Orio F, Palomba S, Longo R A, Lombardi G, Lobo R A. Ovarian size and blood flow in women with polycystic ovary syndrome and their correlations with endocrine parameters.  Fertil Steril. 2005;  84 413-419
  CrossrefPubMedGoogle Scholar
• 32 Agrawal R, Sladkevicius P, Engmann L et al.. Serum vascular endothelial growth factor concentrations and ovarian stromal blood flow are increased in women with polycystic ovaries.  Hum Reprod. 1998;  13 651-655
  CrossrefPubMedGoogle Scholar
• 33 Engmann L, Sladkevicius P, Agrawal R, Bekir J S, Campbell S, Tan S L. Value of ovarian stromal blood flow velocity measurement after pituitary suppression in the prediction of ovarian responsiveness and outcome of in vitro fertilization treatment.  Fertil Steril. 1999;  71 22-29
  CrossrefPubMedGoogle Scholar
• 34 Agrawal R, Conway G, Sladkevicius P et al.. Serum vascular endothelial growth factor and Doppler blood flow velocities in in vitro fertilization: relevance to ovarian hyperstimulation syndrome and polycystic ovaries.  Fertil Steril. 1998;  70 651-658
  CrossrefPubMedGoogle Scholar
• 35 Raine-Fenning N J, Campbell B K, Clewes J S, Johnson I R. The interobserver reliability of ovarian volume measurement is improved with three-dimensional ultrasound, but dependent upon technique.  Ultrasound Med Biol. 2003;  29 1685-1690
  CrossrefPubMedGoogle Scholar
• 36 Jarvela I Y, Mason H D, Sladkevicius P et al.. Characterization of normal and polycystic ovaries using three-dimensional power Doppler ultrasonography.  J Assist Reprod Genet. 2002;  19 582-590
  CrossrefPubMedGoogle Scholar
• 37 Lam P M, Raine-Fenning N. The role of three-dimensional ultrasonography in polycystic ovary syndrome.  Hum Reprod. 2006;  21 2209-2215
  CrossrefPubMedGoogle Scholar
• 38 Allemand M C, Tummon I S, Phy J L, Foong S C, Dumesic D A, Session D R. Diagnosis of polycystic ovaries by three-dimensional transvaginal ultrasound.  Fertil Steril. 2006;  85 214-219
  CrossrefPubMedGoogle Scholar
• 39 Faure N, Prat X, Bastide A, Lemay A. Assessment of ovaries by magnetic resonance imaging in patients presenting with polycystic ovarian syndrome.  Hum Reprod. 1989;  4 468-472
  PubMedGoogle Scholar
• 40 Yoo R Y, Sirlin C B, Gottschalk M, Chang R J. Ovarian imaging by magnetic resonance in obese adolescent girls with polycystic ovary syndrome: a pilot study.  Fertil Steril. 2005;  84 985-995
  CrossrefPubMedGoogle Scholar
• 41 Timor-Tritsch I E, Monteagudo A, Rebarber A, Goldstein S R, Tsymbal T. Transrectal scanning: an alternative when transvaginal scanning is not feasible.  Ultrasound Obstet Gynecol. 2003;  21 473-479
  PubMedGoogle Scholar
• 42 Azziz R, Carmina E, Dewailly D et al.. Positions statement: criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an Androgen Excess Society guideline.  J Clin Endocrinol Metab. 2006;  91 4237-4245
  Google Scholar
• 43 Diamanti-Kandarakis E, Panidis D. Unravelling the phenotypic map of polycystic ovary syndrome (PCOS): a prospective study of 634 women with PCOS.  Clin Endocrinol (Oxf). 2007;  67 735-742
  CrossrefPubMedGoogle Scholar
• 44 Kyei-Mensah A A, LinTan S, Zaidi J, Jacobs H S. Relationship of ovarian stromal volume to serum androgen concentrations in patients with polycystic ovary syndrome.  Hum Reprod. 1998;  13(6) 1437-1441
  CrossrefPubMedGoogle Scholar
• 45 Dolz M, Osborne N G, Blanes J et al.. Polycystic ovarian syndrome: assessment with color Doppler angiography and three-dimensional ultrasonography.  J Ultrasound Med. 1999;  18(4) 303-313
  PubMedGoogle Scholar
• 46 Jarvela I Y, Mason H D, Sladkevicius P et al.. Characterization of normal and polycystic ovaries using three-dimensional power Doppler ultrasonography.  J Assist Reprod Genet. 2002;  19(12) 582-590
  CrossrefPubMedGoogle Scholar
• 47 Pan H A, Wu M H, Cheng Y C, Li C H, Chang F M. Quantification of Doppler signal in polycystic ovarian syndrome using 3D power Doppler ultrasonography.  Hum Reprod. 2002;  17(9) 2484
  CrossrefPubMedGoogle Scholar
• 48 Ng E H, Chan C C, Yeung W S, Ho P C. Comparison of ovarian stromal blood flow between fertile women with normal ovaries and infertile women with polycystic ovary syndrome.  Hum Reprod. 2005;  20(7) 1881-1886
  CrossrefPubMedGoogle Scholar
• 49 Azziz R. Controversy in clinical endocrinology: diagnosis of polycystic ovarian syndrome: the Rotterdam criteria are premature.  J Clin Endocrinol Metab. 2006;  91 781-785
  CrossrefPubMedGoogle Scholar

Misty Blanchette PorterM.D. 

Division of Reproductive Medicine, Departments of Obstetrics and Gynecology and Radiology, Dartmouth-Hitchcock Medical Center

1 Medical Center Drive, Lebanon, NH 03756

Email: Misty.B.Porter@Hitchcock.org